Create Account
Log In
Dark
chart
exchange
Premium
Terminal
Screener
Stocks
Crypto
Forex
Trends
Depth
Close
Check out our Level2View

SVRA
Savara Inc.
stock NASDAQ

Market Open
Aug 11, 2026 12:15:19 PM EDT
5.72USD-0.262%(-0.01)333,591
5.71Bid   5.72Ask   0.01Spread
Pre-market
Aug 11, 2026 9:27:30 AM EDT
5.83USD+1.658%(+0.10)100
After-hours
Aug 10, 2026 4:31:30 PM EDT
5.76USD+0.524%(+0.03)0
OverviewOption ChainMax PainOptionsPrice & VolumeSplitsHistoricalExchange VolumeDark Pool LevelsDark Pool PrintsExchangesShort VolumeShort Interest - DailyShort InterestBorrow Fee (CTB)Failure to Deliver (FTD)ShortsTrendsNewsNews
Jan 4, 2022
08:05AM EST  Savara to Present at the H.C. Wainwright BIOCONNECT Virtual Conference   Business Wire
Dec 2, 2021
04:05PM EST  Savara Announces New Employment Inducement Grant Under NASDAQ Listing Rule 5635(c)(4)   Business Wire
Nov 22, 2021
11:47AM EST  Savara Shares Move Higher; Co Reports In Form4 Filing Director Buys 200K Shares At Average Price Of $1.08/Share   Benzinga
Nov 15, 2021
08:05AM EST  Savara to Participate in Two Upcoming Investor Healthcare Conferences   Business Wire
Nov 12, 2021
08:30AM EST  Savara Q3 Loss/shr $0.07 Vs. Loss/shr $0.18 Prior Year   RTTNews
08:27AM EST  Savara Q3 Net Loss $10.5 Mln Or $0.07/shr Vs Net Loss $11.1 Mln Or $0.18/shr Prior Year   RTTNews
08:15AM EST  Savara Q3 EPS $(0.07) Up From $(0.18) YoY   Benzinga
08:05AM EST  Savara Reports Third Quarter 2021 Financial Results and Provides Business Update   Business Wire
Nov 10, 2021
08:05AM EST  Savara to Present at the Jefferies London Healthcare Conference   Business Wire
Oct 7, 2021
04:05PM EDT  Savara to Present at the Inaugural Piper Sandler Lung Day   Business Wire
Sep 7, 2021
08:05AM EDT  Savara to Participate in Two Upcoming Investor Healthcare Conferences   Business Wire
Sep 3, 2021
08:05AM EDT  Savara Announces New Employment Inducement Grants Under NASDAQ Listing Rule 5635(c)(4)   Business Wire
Aug 12, 2021
04:28PM EDT  Savara Q2 EPS $(0.07) Up From $(0.16) YoY   Benzinga
04:06PM EDT  Savara Reports Second Quarter 2021 Financial Results and Provides Business Update   Business Wire
Jul 7, 2021
08:07AM EDT  Savara On Jul. 6 Entered Sales Agreement With Evercore Pursuant To Which Co. May Offer And Sell From Time To Time Common Stock Of Up To $60M   Benzinga
Jul 6, 2021
04:05PM EDT  Savara Inc Files For Mixed Shelf Offering Of Up To $250M   Benzinga
Jun 30, 2021
10:51AM EDT  Savara Announces First Patient Dosed In Pivotal Phase 3 Autoimmune Pulmonary Alveolar Proteinosis Trial   RTTNews
10:47AM EDT  Savara Announces First Patient Dosed in Pivotal Phase 3 Autoimmune Pulmonary Alveolar Proteinosis (aPAP) Trial   Business Wire
May 26, 2021
08:05AM EDT  Savara to Present at the Jefferies Virtual Healthcare Conference   Business Wire
May 17, 2021
08:05AM EDT  Savara to Present at the Oppenheimer Rare & Orphan Disease Virtual Summit   Business Wire
May 14, 2021
08:05AM EDT  Savara Announces New Employment Inducement Grant Under NASDAQ Listing Rule 5635(c)(4)   Business Wire
May 13, 2021
04:23PM EDT  Savara Q1 EPS $(0.13) Up From $(0.27) YoY   Benzinga
04:06PM EDT  Savara Reports First Quarter 2021 Financial Results and Provides Business Update   Business Wire
Mar 17, 2021
07:43AM EDT  The Daily Biotech Pulse: Merck's Keytruda Gets Label Expansion In Europe, Pfizer To Sell Chinese Biologics Unit, Celcuity Spikes   Benzinga
Mar 16, 2021
02:46PM EDT  Mid-Afternoon Market Update: Crude Oil Down 1%; SunLink Health Systems Shares Spike Higher   Benzinga
02:46PM EDT  Mid-Day Market Update: Dow Falls 100 Points; Can-Fite BioPharma Shares Jump   Benzinga
10:40AM EDT  Thinking About Buying Stock In AstraZeneca, Apple, McDonald's, Savara Or Jabil?   Benzinga
10:38AM EDT  Benzinga's Top Ratings Upgrades, Downgrades For March 16, 2021   Benzinga
08:17AM EDT  The Daily Biotech Pulse: Fulgent Nabs CDC Contract, Enzo Rallies, Solid Biosciences Releases Gene Therapy Data, Moderna Begins Pediatric Vaccine Study   Benzinga
06:21AM EDT  Piper Sandler Initiates Coverage On Savara with Overweight Rating, Announces Price Target of $7   Benzinga
Mar 15, 2021
02:51PM EDT  Savara CFO David Lowrance Reported Purchase of 13,793 @ Avg Price: $1.45/Share in Form 4 Filing   Benzinga
02:50PM EDT  Savara Inc: Lowrance David L (CHIEF FINANCIAL OFFICER) Buys 13,793 @ Avg Price: $1.45 (Form4)   Benzinga
11:09AM EDT  Benzinga's Top Ratings Upgrades, Downgrades For March 15, 2021   Benzinga
09:36AM EDT  Savara Reports Closing Of $130 Mln Public Offering Following Full Exercise Of Underwriters' Option   RTTNews
09:32AM EDT  Savara Announces Closing of $130 Million Public Offering Following Full Exercise of Underwriters' Option   Business Wire
07:26AM EDT  Oppenheimer Initiates Coverage On Savara with Outperform Rating, Announces Price Target of $4   Benzinga
Mar 11, 2021
09:10AM EST  Savara Prices Public Offering Of 45.78 Mln Shares At $1.45 Per Share   RTTNews
08:58AM EST  Savara Prices 45,785,828 Share Common Stock Offering At $1.45/Share   Benzinga
08:57AM EST  Savara Announces Pricing of Public Offering of Common Stock   Business Wire
08:19AM EST  The Daily Biotech Pulse: Contrasting COVID-19 Treatment Readouts From Roche, Vir, Delay In Kadmon's FDA Review, Alzheimer's Data From Prothena   Benzinga
Mar 10, 2021
04:50PM EST  Savara Announces A Common Stock Offering; No Size Disclosed   Benzinga
04:49PM EST  Savara Announces Proposed Public Offering of Common Stock   Business Wire
04:18PM EST  Savara 8-K Shows Co. Entered Master Services Deal With Parexel To Provide Contract Services Related To Clinical Trials Conducted By Co., No Terms Disclosed   Benzinga
Dec 15, 2020
09:54AM EST  10 Biggest Price Target Changes For Tuesday   Benzinga
06:21AM EST  HC Wainwright & Co. Maintains Buy on Savara, Lowers Price Target to $3   Benzinga
Dec 10, 2020
08:11AM EST  Savara Announces Phase 3 AVAIL Trial Missed Primary Endpoint, Co. Stopping Further Development Of AeroVanc   Benzinga
08:10AM EST  Savara Provides Pipeline And Business Update; Co. Discontinues Development Of Apulmiq Program, Focuses Resources On Molgradex In aPAP, Reduces Operating Expenses 'to Align with Streamlined Development Programs'   Benzinga
08:05AM EST  Savara Provides Pipeline and Business Update   Business Wire
Nov 24, 2020
04:15PM EST  Savara Announces Participation in Fireside Chats at Two Upcoming Virtual Investor Healthcare Conferences   Business Wire
Nov 11, 2020
04:05PM EST  Savara to Present at the Jefferies Virtual London Healthcare Conference   Business Wire
Nov 5, 2020
05:52PM EST  Savara Q3 EPS $(0.18) Up From $(0.30) YoY, Sales $256.00K   Benzinga
04:20PM EST  Savara Reports Third Quarter 2020 Financial Results and Provides Business Update   Business Wire
Sep 11, 2020
08:07AM EDT  Savara Reports Chair, CEO, Rob Neville, Resigns; Names Matthew Pauls Chair, Interim CEO   Benzinga
08:05AM EDT  Savara Announces Senior Management Changes   Business Wire
Sep 9, 2020
04:05PM EDT  Savara to Present at the 22nd Annual H.C. Wainwright Annual Investment Conference Being Held Virtually   Business Wire
Sep 8, 2020
08:05AM EDT  Savara Announces New England Journal of Medicine (NEJM) Publication of IMPALA Study Results   Business Wire
Sep 3, 2020
04:10PM EDT  Savara To Discontinue Exploratory ENCORE Study Evaluating Molgradex For Treatment Of NTM Lung Infection In People Living With Cystic Fibrosis   Benzinga
04:05PM EDT  Savara to Discontinue Exploratory ENCORE Study Evaluating Molgradex for the Treatment of NTM Lung Infection in People Living With Cystic Fibrosis (CF)   Business Wire
Aug 6, 2020
04:24PM EDT  Savara Q2 EPS $(0.16) Beats $(0.24) Estimate   Benzinga
04:02PM EDT  Savara Reports Second Quarter 2020 Financial Results and Provides Business Update   Business Wire
Aug 5, 2020
08:05AM EDT  Savara to Present at the 40th Annual Canaccord Genuity Global Growth Conference to be Held Virtually   Business Wire
Jul 30, 2020
08:05AM EDT  Savara to Report Second Quarter 2020 Financial Results and Provide Business Update   Business Wire


Share
About
Pricing
Policies
Markets
API
Info
tz UTC-4
Connect with us
ChartExchange Email
ChartExchange on Discord
ChartExchange on X
ChartExchange on Reddit
ChartExchange on GitHub
ChartExchange on YouTube
© 2020 - 2026 ChartExchange LLC